Centiva Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Buy
+36,057
New +$402K ﹤0.01% 1125
2025
Q2
Sell
-18,290
Closed -$150K 1953
2025
Q1
$150K Buy
+18,290
New +$153K ﹤0.01% 1348
2024
Q2
Sell
-81,965
Closed -$979K 2423
2024
Q1
$979K Buy
81,965
+61,461
+300% +$683K 0.02% 671
2023
Q4
$221K Buy
+20,504
New +$249K 0.01% 1373
2023
Q3
Sell
-65,497
Closed -$784K 2012
2023
Q2
$784K Buy
65,497
+50,365
+333% +$568K 0.02% 657
2023
Q1
$177K Buy
+15,132
New +$221K ﹤0.01% 1263
2022
Q2
Sell
-10,346
Closed -$160K 1929
2022
Q1
$160K Buy
+10,346
New +$131K ﹤0.01% 1329

Other funds holding PTEN

Centiva Capital's PTEN Position: Q2 2026 in Review

Centiva Capital opened a new position in Patterson-UTI (PTEN) in Q2 2026: 36,057 shares worth $331K. The stake represents ﹤0.01% of the portfolio and ranks #1125 among its holdings. This is a return to the name: Centiva Capital previously reported a position in PTEN as recently as Q1 2025.

Centiva Capital first reported a position in PTEN in Q1 2022 and has held it in 7 quarters since. The position peaked at $979K in Q1 2024. 437 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Centiva Capital held 36,057 shares of Patterson-UTI worth $331K as of Q2 2026.
  • Patterson-UTI was a new Centiva Capital position in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1125 holding.
  • Centiva Capital first reported a position in Patterson-UTI in Q1 2022 and has held it in 7 quarters since.
  • Centiva Capital's Patterson-UTI position peaked at $979K in Q1 2024.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.